Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders | Zendy

Daniel B. Rosoff | Zendy; George Davey Smith | Zendy; Falk W. Lohoff | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders

Author(s) -

Daniel B. Rosoff,

George Davey Smith,

Falk W. Lohoff

Publication year - 2020

Publication title -

jama psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.531

H-Index - 365

eISSN - 2168-6238

pISSN - 2168-622X

DOI - 10.1001/jamapsychiatry.2020.3554

Subject(s) - mendelian randomization , medicine , psychiatry , major depressive disorder , anxiety , population , genome wide association study , observational study , odds ratio , clinical psychology , mood , single nucleotide polymorphism , biochemistry , chemistry , environmental health , genetic variants , genotype , gene

Growing evidence suggests that prescription opioid use affects depression and anxiety disorders; however, observational studies are subject to confounding, making causal inference and determining the direction of these associations difficult.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research